In a report released yesterday, Robbie Marcus from J.P. Morgan maintained a Hold rating on Inogen (INGN – Research Report), with a price target of $32.00. The company's shares closed last Friday at $24.94, close to its 52-week low of $23.04. According to TipRanks.com, Marcus is a 4-star analyst with an average return of 8.1% and a 46.2% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Treace Medical Concepts, and Zimmer Biomet Holdings. Currently, the analyst consensus on Inogen is a Moderate Buy with an average price target of $39.00.
https://www.tipranks.com/news/blurbs/inogen-ingn-gets-a-hold-rating-from-j-p-morgan?utm_source=advfn.com&utm_medium=referral